Medical Condition News

RSS

Immune therapy may be an alternate therapeutic approach for treating chronic hepatitis B

Hepatitis B virus (HBV) infection is global in nature and induces several incredible liver diseases, such as chronic hepatitis B (CHB), cirrhosis of the liver (LC) and hepatocellular carcinoma (HCC). A total of 882,000 patients died of HBV-related liver diseases in 2019.

25 Aug 2022

AI can detect Parkinson’s from nighttime breathing patterns

Researchers develop an artificial intelligence-based model to detect Parkinson’s disease and track its progression from nocturnal breathing signals.

25 Aug 2022

Brain stimulation improves memory function in older adults

Researchers evaluate the effectiveness of repetitive neuromodulation in improving the working memory and long-term memory of older adults.

25 Aug 2022

A complex immunological landscape emerges in South Africa after Omicron BA.1/BA.2

Researchers evaluate infection rates and changes in the immunological history of COVID-19 patients over time.

25 Aug 2022

MRI shows brain microstructural changes after mild COVID-19

Researchers investigate fatigue severity and brain microstructural abnormalities in patients who have recovered from mild to moderate COVID-19.

25 Aug 2022

Chinese researchers identify a new molecular mechanism of NASH pathogenesis

Nonalcoholic steatohepatitis (NASH), characterized by liver steatosis, inflammation and injury, has emerged as one of major causes for end-stage liver disease like hepatocellular carcinoma. However, what drives its progression?

25 Aug 2022

ACC publishes guidance on the role of nonstatin therapies for lowering LDL-C levels

To address the current gaps in expert guidance related to the recent development and commercial availability of newer nonstatin agents, the American College of Cardiology published today an expert consensus decision pathway on the role of nonstatin therapies for LDL-C lowering in the management of atherosclerotic cardiovascular disease (ASCVD) risk reduction.

25 Aug 2022

New diagnoses of neurological and psychiatric disorders remain common two years after COVID-19

New diagnoses of disorders including psychosis, dementia, seizures and ‘brain fog’ remain commoner two years after COVID-19 than after other respiratory infections, whereas the increased risks of depression and anxiety after COVID-19 are short-lived and there is no overall excess of cases.

25 Aug 2022

COVID-19 vaccine not linked to increased risk of stroke

Newly compiled data evaluated by researchers in the Department of Neurology and the Smidt Heart Institute at Cedars-Sinai shows that COVID-19 vaccines do not raise stroke risk--but that severe COVID-19 infection does.

24 Aug 2022

How does the human gut microbiome impact menopause?

A recent study summarizes available information on the relationship between menopause and the gut microbiome.

24 Aug 2022

The risk of adverse reactions when herbal medications are taken with cancer drugs

A new study discusses phytovigilance initiatives based on the real-world use of herbal drugs in cancer along with conventional chemotherapy.

24 Aug 2022

Severe COVID-19 increases risk of future cardiovascular events

A recent study determines the relationship between COVID-19 severity and risk of subsequent cardiovascular events in a large cohort.

24 Aug 2022

Fortified human breastmilk alters the microbiota of low-birth-weight infants

A new study discusses how fortified human milk changes the gut microbiome in these babies.

24 Aug 2022

Soft-tissue sarcomas produce a protein that make immune cells 'go bad'

Investigators from Cedars-Sinai Cancer have discovered that cancerous tumors called soft-tissue sarcomas produce a protein that switches immune cells from tumor-attacking to tumor-promoting.

24 Aug 2022

Study investigates associations between MS prevalence and factors driving regional differences

Researchers have known people who live farther from the equator are more likely to develop multiple sclerosis (MS) and have often attributed that to vitamin D exposure.

24 Aug 2022

Targeting Na+/K+ ATPase alpha 1 proteins could help identify novel therapies for blood clots, thrombosis

Targeting Na+/K+ ATPase alpha 1 (ATP1A1) subunit proteins could help identify novel therapies for addressing blood clots and thrombosis, according to a new study by Marshall University researchers.

24 Aug 2022

Researchers discover a new class of more potent and less toxic drugs for leukemia patients

Chemotherapy sucks. The treatments generally have awful side effects, and it's no secret that the drugs involved are often toxic to the patient as well as their cancer.

24 Aug 2022

Functional architecture of the brain's reward system predicts appetite changes in depression

Major depressive disorders are characterized by a significant health burden, including changes in appetite and body weight.

24 Aug 2022

Youth-onset type 2 diabetes climbed 77% amid COVID-19, study shows

Data suggests diagnoses of type 2 diabetes in children are increasing 4-5% per year. Type 2 diabetes occurs when the cells in the body do not respond to insulin, which increases the body's need for insulin.

24 Aug 2022

Changes in brain connections occur very early in Alzheimer's disease

Although a lot is known about brain alterations in symptomatic Alzheimer's disease (AD), less is known about changes in the brain network early in the disease process.

24 Aug 2022

Medical Condition News

Immune therapy may be an alternate therapeutic approach for treating chronic hepatitis B

AI can detect Parkinson’s from nighttime breathing patterns

Brain stimulation improves memory function in older adults

A complex immunological landscape emerges in South Africa after Omicron BA.1/BA.2

MRI shows brain microstructural changes after mild COVID-19

Chinese researchers identify a new molecular mechanism of NASH pathogenesis

ACC publishes guidance on the role of nonstatin therapies for lowering LDL-C levels

New diagnoses of neurological and psychiatric disorders remain common two years after COVID-19

COVID-19 vaccine not linked to increased risk of stroke

How does the human gut microbiome impact menopause?

The risk of adverse reactions when herbal medications are taken with cancer drugs

Severe COVID-19 increases risk of future cardiovascular events

Fortified human breastmilk alters the microbiota of low-birth-weight infants

Soft-tissue sarcomas produce a protein that make immune cells 'go bad'

Study investigates associations between MS prevalence and factors driving regional differences

Targeting Na+/K+ ATPase alpha 1 proteins could help identify novel therapies for blood clots, thrombosis

Researchers discover a new class of more potent and less toxic drugs for leukemia patients

Functional architecture of the brain's reward system predicts appetite changes in depression

Youth-onset type 2 diabetes climbed 77% amid COVID-19, study shows

Changes in brain connections occur very early in Alzheimer's disease

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News